An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab

Exclusion Criteria

• •Inflammatory Bowel Disease
• •HIV Positive
• •Active Hepatitis B or C Infection
• •Pregnant or Breastfeeding
• •no concurrent use of any systemic antibiotics/retinoids/imunosuppressants (require washout period of \>5 half lives)
• •Any medical, psychological or social condition that, in the opinion of the investigator, would jeopardize the health or well being go the participant during any study procedures or the integrity of the data
• •High Suicide Risk as determined by the Columbia Suicide Severity Rating Scale